EU Peptic Ulcer Drugs Market, Segmented by Drug Types (Proton Pump Inhibitors, Potassium-Competitive Acid Blockers, Antacids, H2-Antagonists, Antibiotics and Ulcer Protective Drugs) and by Distribution Channel (Hospital Pharmacies, Private Clinics, Drug Stores and Retail Pharmacies) Growth, Trends and Forecast, 2019-2028
- Published Date: 2022-12-26
- Report ID: 138289
- Pages: 200
-
Format:
Report Overview
The EU Peptic Ulcer Drugs market size stood at around USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period
A peptic ulcer is a sore in the inner lining of the stomach or upper small intestine. Ulcers form when the intestine or stomach's protective layer is broken down. When this happens, digestive juices which contain hydrochloric acid and an enzyme called pepsin can damage the intestine or stomach tissue
Market Drivers
The rise in the awareness about peptic ulcers in individuals is one of the emerging trends in the Europe peptic ulcer drugs market in the coming years. The growing Europe market is attributable to the growing number of patients suffering from peptic ulcers along with the rising healthcare expenditure in European countries like U.K., Germany and France
1. EU Peptic Ulcer Drugs Market Overview
A. Market Size
2. EU Peptic Ulcer Drugs Market Growth Drivers
A. Rise in the awareness about peptic ulcers
B. Growing number of patients and rising healthcare expenditure
3. EU Peptic Ulcer Drugs Market Segmentation.
A. By Drug Types
I. Proton Pump Inhibitors
II. Potassium-Competitive Acid Blockers
III. Antacids
IV. H2-Antagonists
V. Antibiotics
VI. Ulcer Protective Drugs
B. By Distribution Channel
I. Hospital Pharmacies
II. Private Clinics
III. Drug Stores
IV. Retail Pharmacies
4. EU Peptic Ulcer Drugs Market Major Market Share.......................
A. Market Analysis, Insights and Forecast by Revenue
5. Competitive Landscape
A. Major Players
B. Products in Pipeline
6. Key Company Profiles..
A. GlaxoSmithKline Company overview, Product & Services, Strategies & Financials
B. Pfizer Company overview, Product & Services, Strategies & Financials
C. Takeda Pharmaceuticals Company overview, Product & Services, Strategies & Financials
7. Healthcare Policies and Regulatory Landscape.
A. Policy Changes and Reimbursement Scenario
8. Factors Driving Market Growth
A. Key Industry Developments
B. Mergers and Acquisitions
9. Potential Growth Opportunities
A. Market Opportunities
B. Future Trends
10. Conclusion
Call Us
( India toll free )
+91 835 605 0278
( US toll free )
+1 800 601 6071
Drop us an email at
sales@prudentmarkets.com
Get your pre and post sales queries resolved by our Subject matter experts.
We will assist you to customize the report to fit your research needs.
Our prime focus is to provide qualitative and accurate data.
Feel free to order a sample report before purchase.
Your personal and confidential information is safe and secured.
